Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1976 Jul;184(1):60–64. doi: 10.1097/00000658-197607000-00010

Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient.

E M Copeland, B V Fadyen Jr, S J Dudrick
PMCID: PMC1344308  PMID: 820290

Abstract

Forty-seven cancer patients were selected for study based on their candidacy for hyperalimentation. Each patient received selected skin test antigens intradermally in the forearm prior to the initiation of hyperalimentation, and at 7-day intervals throughout treatment with either chemotherapy, radiation therapy or surgery. Of 23 patients who received chemotherapy, 17 initially had negative skin tests. Thirteen of these patients had positive skin tests after an average of 11.4 +/- 5.5 days of hyperalimentation. Response to chemotherapy occurred only in hyperalimentation. Response to chemotherapy occurred only in those patients whose skin tests were positive, and conversion of skin test reactivity to positive occurred before clinical regression of metastatic disease. No patient who received radiation therapy developed or retained positive skin test reactivity, although nutritional repletion was considered satisfactory in each patient. Surgical patients whose skin tests converted to positive or remained positive preoperatively had an uncomplicated postoperative recovery, whereas 2 of 4 patients whose skin tests remained negative expired postoperatively. Absence of established delayed hypersensitivity in the cancer patient who is treated with chemotherapy or surgery is probably secondary to generalized malnutrition, and established cell-mediated immunity can be restored by proper nutritional repletion.

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosworth J. L., Ghossein N. A., Brooks T. L. Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival. Cancer. 1975 Aug;36(2):353–358. doi: 10.1002/1097-0142(197508)36:2<353::aid-cncr2820360209>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  2. Chandra R. K. Rosette-forming T lymphocytes and cell-mediated immunity in malnutrition. Br Med J. 1974 Sep 7;3(5931):608–609. doi: 10.1136/bmj.3.5931.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cheema A. R., Hersh E. M. Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer. 1971 Oct;28(4):851–855. doi: 10.1002/1097-0142(1971)28:4<851::aid-cncr2820280408>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  4. Copeland E. M., 3rd, MacFadyen B. V., Jr, McGown C., Dudrick S. J. The use of hyperalimentation in patients with potential sepsis. Surg Gynecol Obstet. 1974 Mar;138(3):377–380. [PubMed] [Google Scholar]
  5. Copeland E. M., Macfayden B. V., Jr, Dudrick S. J. Intravenous hyperalimentation in cancer patients. J Surg Res. 1974 Mar;16(3):241–247. doi: 10.1016/0022-4804(74)90038-9. [DOI] [PubMed] [Google Scholar]
  6. Cosimi A. B., Brunstetter F. H., Kemmerer W. T., Miller B. N. Cellular immune competence of breast cancer patients receiving radiotherapy. Arch Surg. 1973 Oct;107(4):531–535. doi: 10.1001/archsurg.1973.01350220015005. [DOI] [PubMed] [Google Scholar]
  7. Eilber F. R., Morton D. L. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  8. Hersh E. M., Carbone P. P., Wong V. G., Freireich E. J. Inhibition of the primary immune response in man by anti-metabolites. Cancer Res. 1965 Aug;25(7):997–1001. [PubMed] [Google Scholar]
  9. Hersh E. M., Gutterman J. U., Mavligit G., McCredie K. B., Bodey G. P., Freireich E. J., Rossen R. D., Butler W. T. Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatment. Transplant Proc. 1973 Sep;5(3):1191–1195. [PubMed] [Google Scholar]
  10. Hersh E. M., Whitecar J. P., Jr, McCredie K. B., Bodey G. P., Sr, Freireich E. J. Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med. 1971 Nov;285(22):1211–1216. doi: 10.1056/NEJM197111252852201. [DOI] [PubMed] [Google Scholar]
  11. LAMB D., PILNEY F., KELLY W. D., GOOD R. A. A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas. J Immunol. 1962 Oct;89:555–558. [PubMed] [Google Scholar]
  12. Law D. K., Dudrick S. J., Abdou N. I. Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion. Ann Intern Med. 1973 Oct;79(4):545–550. doi: 10.7326/0003-4819-79-4-545. [DOI] [PubMed] [Google Scholar]
  13. Law D. K., Dudrick S. J., Abdou N. I. The effect of dietary protein depletion on immunocompetence: the importance of nutritional repletion prior to immunologic induction. Ann Surg. 1974 Feb;179(2):168–173. doi: 10.1097/00000658-197402000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohno R., Hersh E. M. Immunosuppressive effects of L-asparaginase. Cancer Res. 1970 Jun;30(6):1605–1611. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES